BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 26665550)

  • 21. Trinucleotide insertion in the SMN2 promoter may not be related to the clinical phenotype of SMA.
    Harahap NI; Takeuchi A; Yusoff S; Tominaga K; Okinaga T; Kitai Y; Takarada T; Kubo Y; Saito K; Sa'adah N; Nurputra DK; Nishimura N; Saito T; Nishio H
    Brain Dev; 2015 Aug; 37(7):669-76. PubMed ID: 25459970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a reliable method for detection of non-homozygous patients with spinal muscular atrophy].
    Long MJ; Song F; Qu YJ; Meng Y; Wang H; Jin YW; Huang SZ
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1259-63. PubMed ID: 18844099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypes of SMA patients retaining SMN1 with intragenic mutation.
    Wijaya YOS; Ar Rohmah M; Niba ETE; Morisada N; Noguchi Y; Hidaka Y; Ozasa S; Inoue T; Shimazu T; Takahashi Y; Tozawa T; Chiyonobu T; Inoue T; Shiroshita T; Yokoyama A; Okamoto K; Awano H; Takeshima Y; Saito T; Saito K; Nishio H; Shinohara M
    Brain Dev; 2021 Aug; 43(7):745-758. PubMed ID: 33892995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene.
    Niba ETE; Nishio H; Wijaya YOS; Lai PS; Tozawa T; Chiyonobu T; Yamadera M; Okamoto K; Awano H; Takeshima Y; Saito T; Shinohara M
    Brain Dev; 2021 Feb; 43(2):294-302. PubMed ID: 33036822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Algorithm for Infants Diagnosed with Spinal Muscular Atrophy through Newborn Screening.
    Glascock J; Sampson J; Haidet-Phillips A; Connolly A; Darras B; Day J; Finkel R; Howell RR; Klinger K; Kuntz N; Prior T; Shieh PB; Crawford TO; Kerr D; Jarecki J
    J Neuromuscul Dis; 2018; 5(2):145-158. PubMed ID: 29614695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of point mutations in the SMN1 gene in SMA patients bearing a single SMN1 copy.
    Zapletalová E; Hedvicáková P; Kozák L; Vondrácek P; Gaillyová R; Maríková T; Kalina Z; Jüttnerová V; Fajkus J; Fajkusová L
    Neuromuscul Disord; 2007 Jun; 17(6):476-81. PubMed ID: 17475491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SMA Diagnosis: Detection of SMN1 Deletion with Real-Time mCOP-PCR System Using Fresh Blood DNA.
    Niba ETE; Ar Rochmah M; Harahap NIF; Awano H; Morioka I; Iijima K; Saito T; Saito K; Takeuchi A; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2017 Dec; 63(3):E80-E83. PubMed ID: 29434179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spinal muscular atrophy patient detection and carrier screening using dried blood spots on filter paper.
    Harahap NI; Harahap IS; Kaszynski RH; Nurputra DK; Hartomo TB; Pham HT; Yamamoto T; Morikawa S; Nishimura N; Rusdi I; Widiastuti R; Nishio H
    Genet Test Mol Biomarkers; 2012 Feb; 16(2):123-9. PubMed ID: 21942573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.
    He J; Zhang QJ; Lin QF; Chen YF; Lin XZ; Lin MT; Murong SX; Wang N; Chen WJ
    Gene; 2013 Apr; 518(2):325-9. PubMed ID: 23352792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-world evidence: Risdiplam in a patient with spinal muscular atrophy type I with a novel splicing mutation and one SMN2 copy.
    Ma K; Zhang K; Chen D; Wang C; Abdalla M; Zhang H; Tian R; Liu Y; Song L; Zhang X; Liu F; Liu G; Wang D
    Hum Mol Genet; 2024 Jun; 33(13):1120-1130. PubMed ID: 38520738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal fluorescent multiplex PCR and capillary electrophoresis for evaluation of gene conversion between SMN1 and SMN2 in spinal muscular atrophy.
    Wang CC; Jong YJ; Chang JG; Chen YL; Wu SM
    Anal Bioanal Chem; 2010 Jul; 397(6):2375-83. PubMed ID: 20563565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR.
    Stabley DL; Holbrook J; Scavina M; Crawford TO; Swoboda KJ; Robbins KM; Butchbach MER
    Neurogenetics; 2021 Mar; 22(1):53-64. PubMed ID: 33415588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Quantitative analysis of SMN2 based on real-time PCR: correlation of clinical severity and SMN2 gene dosage].
    Saito M; Chen Y; Mizuguchi M; Igarashi T
    No To Hattatsu; 2005 Sep; 37(5):407-12. PubMed ID: 16164247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMN2 and NAIP gene dosages in Vietnamese patients with spinal muscular atrophy.
    Tran VK; Sasongko TH; Hong DD; Hoan NT; Dung VC; Lee MJ; Gunadi ; Takeshima Y; Matsuo M; Nishio H
    Pediatr Int; 2008 Jun; 50(3):346-51. PubMed ID: 18533950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients.
    Brkušanin M; Kosać A; Jovanović V; Pešović J; Brajušković G; Dimitrijević N; Todorović S; Romac S; Milić Rašić V; Savić-Pavićević D
    J Hum Genet; 2015 Nov; 60(11):723-8. PubMed ID: 26311540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn screening for spinal muscular atrophy by calibrated short-amplicon melt profiling.
    Dobrowolski SF; Pham HT; Downes FP; Prior TW; Naylor EW; Swoboda KJ
    Clin Chem; 2012 Jun; 58(6):1033-9. PubMed ID: 22490618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number.
    Wirth B; Brichta L; Schrank B; Lochmüller H; Blick S; Baasner A; Heller R
    Hum Genet; 2006 May; 119(4):422-8. PubMed ID: 16508748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.
    Ruhno C; McGovern VL; Avenarius MR; Snyder PJ; Prior TW; Nery FC; Muhtaseb A; Roggenbuck JS; Kissel JT; Sansone VA; Siranosian JJ; Johnstone AJ; Nwe PH; Zhang RZ; Swoboda KJ; Burghes AHM
    Hum Genet; 2019 Mar; 138(3):241-256. PubMed ID: 30788592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A paucisymptomatic neuromuscular disease mimicking type III 5q-SMA with complex rearrangements in the SMN gene.
    Lohkamp LN; von Au K; Goebel HH; Kress W; Grieben U; Drossel K; Garbes L; Wirth B; Heppner FL; Stenzel W
    J Child Neurol; 2014 Feb; 29(2):254-9. PubMed ID: 24334346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.